# US 2015/0307921 A1 · Self-contained biological assay apparatus, methods, and applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0307921 A1
- Document ID: US20150307921A1
- Status: Published application
- Kind: A1
- Application number: 14/798,719
- Filed: 2015-07-14
- Published: 2015-10-29
- Earliest claimed: 2010-02-23
- Assignees: Rheonix, Inc.
- Applicants: Rheonix, Inc.
- Inventors: Peng Zhou; Lincoln C. Young; Benjamin Thomas; Zongyuan Chen; Todd Roswech; Gwendolyn Spizz; Rubina Yasmin; Greg Mouchka
- Web page: https://patentgrep.com/patent/US20150307921A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- B01L 3/527: {for a plurality of reagents}
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6813: Hybridisation assays
- C12Q 1/6825: Nucleic acid detection involving sensors
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6846: {Common amplification features}
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/708: {for papilloma}
- G01N 35/10: Devices for transferring samples {or any liquids} to, in, or from, the analysis apparatus, e.g. suction devices, injection devices {(G01N35/0099 takes precedence)}
- G01N 35/1002: {Reagent dispensers}
- B01L 3/502738: {characterised by integrated valves (throttle valves in microfluidic sample containers B01L3/502746)}
- B01L 3/523: {with means for closing or opening}
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2200/14: Process control and prevention of errors
- B01L 2300/0627: Sensor or part of a sensor is integrated
- B01L 2300/0654: Lenses; Optical fibres
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0819: Microarrays; Biochips
- B01L 2300/0861: Configuration of multiple channels and/or chambers in a single devices
- B01L 2300/18: Means for temperature control
- B01L 2400/0481: squeezing of channels or chambers
- B01L 2400/0487: fluid pressure, pneumatics
- B01L 2400/0655: pinch valves
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- G01N 2035/00346: {Heating or cooling arrangements}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A self-contained, fully automated, biological assay-performing apparatus includes a housing; a dispensing platform including a controllably-movable reagent dispensing system, disposed in the housing; a reagent supply component disposed in the housing; a pneumatic manifold removably disposed in the housing in a space shared by the dispensing platform, removably coupled to a fluidic transport layer and a plurality of reservoirs, wherein the fluidic transport layer, the reservoirs, and a test sample to be introduced therein are disposed in the housing in the space separate from the dispensing platform; a pneumatic supply system removably coupled to the pneumatic manifold in the housing in a space separate from the dispensing platform; and a control system coupled to at least one of the dispensing platform and the pneumatic supply system, disposed in the housing.

## Claims

### Claim 1

(canceled)

### Claim 2

A self-contained, biological assay apparatus, comprising:
a housing;
a dispensing platform including a controllably-movable reagent dispensing system, disposed in the housing;
a reagent supply component disposed in the housing;
a pneumatic manifold removeably disposed in the housing in a space shared by the dispensing platform, removeably coupled to a microfluidic system having a fluidic transport layer and a plurality of reservoirs which are fluidly connected to said fluidic transport layer,
wherein the fluidic transport layer, the reservoirs, and a test sample to be introduced therein are disposed in the housing in the space separate from the dispensing platform;
a pneumatic supply system removeably coupled to the pneumatic manifold in the housing in a space separate from the dispensing platform; and
a control system coupled to at least one of the dispensing platform and the pneumatic supply system, disposed in the housing,
wherein the apparatus is characterized as a self-contained, fully automated biological assay-performing apparatus,
further wherein the introduced test sample is transported from a starting location in the fluidic transport layer to the analysis reservoir separately from any other samples and separately from the pneumatic manifold and the dispensing system.

### Claim 3 (depends on 2)

The apparatus of claim 2, wherein the dispensing platform further comprises:
a motion control system operatively coupled to the reagent dispensing system,
wherein the reagent dispensing system includes a reagent dispenser component having a distal dispensing end; and
a camera connected to the reagent dispensing system having a field of view that includes at least a selected region of interest of the reservoirs.

### Claim 4 (depends on 3)

The apparatus of claim 3, wherein the reagent dispenser component is an elongate needle structure having a length, L, and a selected bore size.

### Claim 5 (depends on 4)

The apparatus of claim 4, wherein the reagent dispensing system further includes a reagent storage structure fluidly connected to the reagent dispenser component, wherein the reagent storage structure has a selected dimension that operatively coincides with the selected bore size.

### Claim 6 (depends on 5)

The apparatus of claim 5, wherein the reagent storage structure is a length of tubing.

### Claim 7 (depends on 3)

The apparatus of claim 3, wherein the reagent dispenser component is a plurality of elongate needle structures of length, L, having different respective, selected bore sizes.

### Claim 8 (depends on 7)

The apparatus of claim 7, wherein the reagent dispensing system further includes a plurality of reagent storage structures that are respectively fluidly connected to the plurality of reagent dispenser components, wherein each reagent storage structure has a selected dimension that operatively coincides with the respective selected bore size.

### Claim 9 (depends on 8)

The apparatus of claim 8, wherein each of the reagent storage structures is a length of tubing.

### Claim 10 (depends on 8)

The apparatus of claim 8, having only two reagent storage structures that are respectively fluidly connected to two reagent dispenser components, wherein one of the reagent dispenser components has a bore diameter bi, 0.003<bi<0.018 inches and the other reagent dispenser component has a bore diameter b2, 0.015<b2<0.030 inches.

### Claim 11 (depends on 2)

The apparatus of claim 2, wherein the pneumatic manifold is interfaced with the microfluidic system.

### Claim 12 (depends on 11)

The apparatus of claim 11, wherein the microfluidic system further comprises a multi-layer, monolithic, polymeric, non-elastomeric microfluidic component having a given configuration of microfeatures including a plurality of pneumatically-activated diaphragms.

### Claim 13 (depends on 12)

The apparatus of claim 12, wherein the pneumatic manifold has a plurality of pneumatic-only ports on an underside thereof, and a plurality of pneumatic-only channels disposed therein in fluid connection with a plurality of valves in the fluidic transport layer and the plurality of pneumatic-only ports, wherein said plurality of pneumatic ports have a fixed configuration, and said plurality of pneumatic-only channels have a given configuration corresponding to a given configuration of the plurality of pneumatically-activated diaphragms in the fluidic transport layer.

### Claim 14 (depends on 13)

The apparatus of claim 13, wherein the pneumatic supply system further comprises a plurality of aperture tubes that provide a passage of the pneumatic signal there through, in fluid connection with said plurality of pneumatic-only ports, wherein said plurality of aperture tubes have a fixed configuration corresponding to the fixed configuration of the plurality of pneumatic-only ports of the pneumatic manifold, removeably connected to the pneumatic manifold.

### Claim 15 (depends on 12)

The apparatus of claim 12, wherein each multi-layer, monolithic microfluidic component further comprises:
a polymeric, non-elastomeric substrate having a plurality of fluid channels disposed therein, each of the fluid channels having an inlet end and an outlet end;
at least one reagent reservoir of a type capable of holding a reagent material;
at least one bi-directional diaphragm pump comprising at least three non-elastomeric membrane-based diaphragm valve structures; and
a valve disposed in fluid coupling with the at least one reagent reservoir and at least one of the inlet ends,
wherein the valve is adapted to controllably direct a flow of the material from the at least one reagent reservoir to a plurality of reservoirs via at least one of the channels coupled to the valve,
further wherein each multi-layer, monolithic microfluidic component consists of a non-elastomeric, polymeric material.

### Claim 16 (depends on 15)

The apparatus of claim 15, wherein each substrate further comprises a plurality of analysis reservoirs, each analysis reservoir including an analysis system disposed therein.

### Claim 17 (depends on 15)

The apparatus of claim 15, wherein the analysis system is one of colorimetric, fluorescent colorimetric, chemiluminescent, electrochemical, electrophoretic, lateral flow, protein microarray, nucleic acid microarray, fluorescent.

### Claim 18 (depends on 15)

The apparatus of claim 15, further comprising a securing-ring structure having a plurality of perimeter indentations, wherein the analysis membrane is operatively engaged with the securing-ring structure.

### Claim 19 (depends on 18)

The apparatus of claim 18, wherein the reservoir has at least a partial inner perimetal shelf upon which the analysis membrane is disposed.

### Claim 20 (depends on 18)

The apparatus of claim 18, wherein the securing-ring structure comprises two opposing ring structures each having a plurality of perimeter indentations, further wherein the analysis membrane is disposed intermediate the two opposing ring structures.

### Claim 21 (depends on 16)

The apparatus of claim 16, further comprising a heater.

### Claim 22 (depends on 21)

The apparatus of claim 21, wherein the heater is disposed in heating proximity to a heatable, magnetically engageable reservoir.

### Claim 23 (depends on 15)

The apparatus of claim 15, further comprising:
a tube mounting layer attached to a bottom surface of the substrate including a plurality of tubes each having a proximal end that is fluidly connected to a respective fluidic channel and a distal end projecting downwardly perpendicularly from the substrate; and
a respective plurality of amplification/reaction chambers attached at a top region thereof to the tube mounting layer such that the distal end of each tube is disposed substantially near a bottom region thereof.

### Claim 24 (depends on 23)

The apparatus of claim 23, further comprising a heater for elevating a temperature in each of the amplification/reaction chambers.

### Claim 25 (depends on 12)

The apparatus of claim 12, further comprising a magnetic assembly operably disposed under a reservoir or channel, wherein the magnetic assembly further comprises a magnet, a magnet holder, a piston rod, and a pneumatic piston assembly (alternatively the piston assembly may be motor or electromagnetically activated).

### Claim 26 (depends on 25)

The apparatus of claim 25, further comprising a heater assembly operably connected to the magnetic assembly.

### Claim 27

An automated process for isolating, amplifying, and analyzing a target nucleic acid sequence that may be present in a fluid test sample, comprising:
providing a pneumatic manifold that operates a microfluidic system having a fluidic transport layer and a fluidic channel disposed therein, and reservoirs attached thereto;
introducing the fluid test sample into the fluidic channel;
providing at least one reagent to the channel from at least one respective reservoir that is in fluid connection with the fluidic transport layer;
combining the fluid test sample and the at least one reagent in a region of the fluidic transport layer, reservoir or amplification reactor;
transporting the fluid test sample to a temperature-controlled amplification/reaction reactor that is in operative communication with the fluidic transport layer;
incubating the fluid test sample in the amplification/reaction reactor under conditions sufficient to permit the target nucleic acid sequence to be amplified;
transporting the fluid test sample to an analysis reservoir; and
analyzing the amplified target nucleic acid sequence from the test sample,
wherein the test sample is transported from a starting location in the fluidic transport layer to the analysis reservoir separately from any other samples and separately from the pneumatic manifold and the dispensing system.

### Claim 28 (depends on 27)

The automated process of claim 27, wherein the transporting and combining steps are accomplished by pumping the fluid test sample and the volume of at least one reagent through the fluidic transport layer via at least one multi-valve diaphragm pump that is operated by the pneumatic manifold.

### Claim 29 (depends on 27)

The automated process of claim 27, wherein the analyzing step further comprises performing a microarray analysis in a microarray analysis reservoir in the microfluidic system.

### Claim 30 (depends on 29)

The automated process of claim 29, further comprising providing a microarray analysis membrane in the microarray analysis reservoir;
flowing a fluid over a top surface of the microarray analysis membrane; and
removing the fluid substantially through a fluid exit route along a periphery of the microarray analysis membrane.

### Claim 31 (depends on 29)

The automated process of claim 29, further comprising providing a microarray analysis membrane in the microarray analysis reservoir; and,
flowing a fluid alternatively back and forth over a top surface of the microarray analysis membrane.

### Claim 32 (depends on 29)

The automated process of claim 29, further comprising providing heat to the microarray analysis membrane.

### Claim 33 (depends on 27)

The automated process of claim 27, wherein the target nucleic acid sequence is associated with a disease or disorder of interest, an infectious agent, a pathogen, a predisposition for cancer, or a predisposition for sensitivity to a drug, pharmaceutical composition, chemical or compound of interest.

### Claim 34 (depends on 27)

The automated process of claim 27, wherein the target nucleic acid sequence comprises a SNP.

### Claim 35 (depends on 33)

The automated process of claim 33, wherein the disease or disorder is HPV or sepsis.

### Claim 36 (depends on 33)

The automated process of claim 33, wherein the target nucleic acid sequence is associated with predisposition for warfarin sensitivity or predisposition for anticoagulation in response to warfarin treatment.

### Claim 37 (depends on 27)

The automated process of claim 27, wherein the analyzing step comprises detecting an interaction between the amplified target nucleic acid sequence and a probe for the target nucleic acid sequence.

### Claim 38 (depends on 37)

The automated process of claim 37, wherein the analyzing step comprises:
determining presence of, or predisposition for:
the disease or disorder of interest,
the infectious agent,
the pathogen, cancer, or
sensitivity to the drug, pharmaceutical composition, chemical or compound of interest.

### Claim 39 (depends on 27)

The automated process of claim 27, wherein the analyzing step comprises:
determining an amount or level of the amplified target nucleic acid sequence and wherein the method further comprises comparing the amount or level with a preselected amount or level of the target nucleic acid sequence.

### Claim 40 (depends on 39)

The automated process of claim 39 wherein a difference between the amount or level and the preselected amount or level is indicative of presence of, or predisposition for:
a disease or disorder of interest,
an infectious agent,
a pathogen,
cancer, or
sensitivity to a drug, pharmaceutical composition, chemical or compound of interest.
